Catalent Inc (0C8.SG)
- Simply Wall St.
Is Catalent, Inc.'s (NYSE:CTLT) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Catalent (NYSE:CTLT) has had a great run on the share market with its stock up by a significant 19% over the last...
- Zacks
Taro Pharmaceutical (TARO) Lags Q3 Earnings and Revenue Estimates
Taro (TARO) delivered earnings and revenue surprises of -78.16% and 14.66%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- Business Wire
Catalent, Inc. Announces Second Quarter Fiscal Year 2023 Earnings Conference Webcast
SOMERSET, N.J., January 20, 2023--Catalent, Inc. (NYSE: CTLT), the global leader in enabling pharma, biotech, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that it will release financial results for the second quarter of fiscal year 2023 ended December 31, 2022, before the market open on Tuesday, February 7, 2023. The Company’s management will host a webcast to discuss the results at 8:15 a.m. ET
